News
List today: Mission Produce, Inc. AVO: This fruits producer has seen the Zacks Consensus Estimate for its current year ...
BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 29th: GDS Holdings Limited GDS: This data center operator from China has a Zacks Rank #1 ...
An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...
A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...
5d
InvestorsHub on MSNPfizer and BioNTech Receive Positive EMA Backing for Updated COVID VaccinePfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
BioNTech, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about 17% over the ...
Türeci co-founded BioNTech, a German company that partnered with pharmaceutical giant Pfizer to develop the first U.S.-authorized COVID-19 vaccine.
BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, its CEO Ugur ...
Pfizer and BioNTech are confident they can have a vaccine against the novel coronavirus ready for regulatory approval by the middle of October or early November, BioNTech CEO and co-founder Ugur ...
BioNTech stock, a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, declined by almost 31% over the last month, considerably underperforming the S&P 500 which remained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results